CytoDyn (CYDY) Payables (2011 - 2026)
CytoDyn's (CYDY) quarterly Payables came in at $22.9 million in Q1 2026, down 0.74% YoY from $23.0 million in Q1 2025, and down 1.73% on a QoQ basis from $23.3 million in Q4 2025.
CytoDyn (CYDY) Payables (2011 - 2026) Analysis & Trends
CytoDyn (CYDY) has 16 years of Payables data on file, last reported at $22.9 million in Q1 2026.
- Quarterly Payables fell 0.74% year-over-year to $22.9 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $22.9 million (down 0.74% YoY) and the FY2025 annual result came in at $23.0 million, down 36.84% from the prior year.
- Payables retreated to $22.9 million in Q1 2026, from $23.3 million in the prior quarter.
- In the past five years, Payables ranged from a high of $73.4 million in Q3 2022 to a low of $21.3 million in Q3 2024.
- A 5-year average of $48.7 million and a median of $66.0 million in 2022 frame the typical range for Payables.
- Annual changes were most pronounced in 2022 — Payables advanced 17.91% — and 2024, when it tumbled 70.72%.
- Tracing CYDY's Payables over 5 years: stood at $72.5 million in 2022, then fell by 5.63% to $68.4 million in 2023, then sank by 68.17% to $21.8 million in 2024, then increased by 6.8% to $23.3 million in 2025, then fell by 1.73% to $22.9 million in 2026.
- The last three Payables figures came in at $22.9 million (Q1 2026), $23.3 million (Q4 2025), and $22.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | CytoDyn | 258.01 Mn | 258.01 Mn | - | 22.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 22.85 Mn |
| Nov 30, 2025 | 23.26 Mn |
| Aug 31, 2025 | 22.82 Mn |
| May 31, 2025 | 22.96 Mn |
| Feb 28, 2025 | 23.02 Mn |
| Nov 30, 2024 | 21.78 Mn |
| Aug 31, 2024 | 21.32 Mn |
| May 31, 2024 | 36.35 Mn |
| Feb 29, 2024 | 72.01 Mn |
| Nov 30, 2023 | 68.41 Mn |
| Aug 31, 2023 | 72.83 Mn |
| May 31, 2023 | 68.11 Mn |
| Feb 28, 2023 | 68.08 Mn |
| Nov 30, 2022 | 72.49 Mn |
| Aug 31, 2022 | 73.36 Mn |
| May 31, 2022 | 71.95 Mn |
| Feb 28, 2022 | 66.04 Mn |
| Nov 30, 2021 | 61.48 Mn |
| Aug 31, 2021 | 68.97 Mn |
| May 31, 2021 | 68.55 Mn |